Reports Q1 revenue $250M vs $228M last year. “USANA (USNA) is off to a solid start to the year as we continue to execute our growth strategy through our core direct sales business and our recently acquired direct-to-consumer business, Hiya. We are seeing encouraging signs in our direct sales business with net sales and Active Customers growing modestly on a sequential basis for the second consecutive quarter,” said Jim Brown, President and Chief Executive Officer.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on USNA:
- USNA Upcoming Earnings Report: What to Expect?
- Usana says Celavive Resurfacing Serum ‘well-tolerated’ in study
- USANA Health Sciences Faces Market Risk with Uncertain Hiya Acquisition Benefits
- USANA Health Sciences Earnings Call Highlights Growth and Strategic Moves
- USANA Health Sciences Reports 2024 Earnings and 2025 Outlook